ERIS Lifesciences consolidated net profit rises 21.74% in the March 2021 quarter

Sales rise 12.36% to Rs 274.25 crore

Net profit of ERIS Lifesciences rose 21.74% to Rs 68.25 crore in the quarter ended March 2021 as against Rs 56.06 crore during the previous quarter ended March 2020. Sales rose 12.36% to Rs 274.25 crore in the quarter ended March 2021 as against Rs 244.09 crore during the previous quarter ended March 2020.

For the full year,net profit rose 19.78% to Rs 355.14 crore in the year ended March 2021 as against Rs 296.50 crore during the previous year ended March 2020. Sales rose 12.71% to Rs 1192.64 crore in the year ended March 2021 as against Rs 1058.18 crore during the previous year ended March 2020.

 

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales274.25244.09 12 1192.641058.18 13 OPM %34.4631.59 -36.1034.81 - PBDT96.1976.01 27 437.48381.61 15 PBT84.7361.67 37 394.50331.35 19 NP68.2556.06 22 355.14296.50 20

Powered by Capital Market - Live News